CAM
AGN

Cresset Asset Management’s Allergan plc AGN Stock Holding History

Cresset Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,952
Closed -$523K – 772
2020
Q1 		$523K Buy
2,952
+1,312
+80% +$247K 0.02% 278
2019
Q4 		$313K Buy
1,640
+92
+6% +$16.6K 0.01% 414
2019
Q3 		$261K Buy
+1,548
New +$252K 0.01% 424
2019
Q2 		– Sell
-1,584
Closed -$232K – 2015
2019
Q1 		$232K Buy
1,584
+972
+159% +$141K 0.01% 339
2018
Q4 		$82K Buy
+612
New +$100K ﹤0.01% 374

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Cresset Asset Management's AGN Position: Q2 2020 in Review

Cresset Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,952 shares — an estimated $523K sold.

Cresset Asset Management first reported a position in AGN in Q4 2018 and held it in 5 quarters. The position peaked at $523K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cresset Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cresset Asset Management sold 2,952 Allergan plc shares in Q2 2020, an estimated $523K.
  • Cresset Asset Management first reported a position in Allergan plc in Q4 2018 and held it in 5 quarters.
  • Cresset Asset Management's Allergan plc position peaked at $523K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cresset Asset Management's 13F filing for Q2 2020, filed 4 Aug 2020.